Add BrightSurf on Google Email

Innate immune response may predict COVID-19 severity

A new study from Karolinska Institutet in Sweden found that COVID-19 disease severity is linked to the characteristics of white blood cells called granulocytes. Combined measurements of granulocyte characteristics and widely used biomarkers can predict key clinical features such as respiratory function and multiorgan failure.

SourceKarolinska Institutet·JournalProceedings of the National Academy of Sciences·DateSep 23, 2021

Discovery of rapid-response signaling platform suggests new path for blocking allergic inflammation

A study by Cincinnati Children's Hospital Medical Center has identified a common biological response platform that could help alleviate allergic inflammation. The research suggests that inhibiting this pathway may provide a unique opportunity to counteract type 2 immunity and reduce allergic reactions.

SourceCincinnati Children's Hospital Medical Center·JournalNature Immunology·DateSep 16, 2021

When suppressing immunity is a good thing

A team of researchers from Hokkaido University found that a receptor, known for its role in mediating dioxin toxicity, also regulates the body's innate immune response to viral infections. The activation of this receptor negatively regulates the production of an antiviral protein called type I interferon.

SourceHokkaido University·JournalNature Immunology·DateJul 1, 2016

Bat 'super immunity' could help protect people

Bats have a unique ability to carry but remain unaffected by lethal diseases due to their constant immune response. The Australian black flying fox has only three interferons, which is a fraction of the number found in people, yet it can control viral infections that are lethal in humans.

SourceCSIRO Australia·JournalProceedings of the National Academy of Sciences·DateFeb 22, 2016